Preclinical evaluation of an innovative dietary intervention for non-alcoholic hepatic steatosis in Sprague-Dawley rats
By: Rodica Talmaci and Irina Mihaela Matran
References
- Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202–209
- Younossi ZM. Non-alcoholic fatty liver disease – A global public health perspective. Jour Hepatol. 2019; 70(3):531-544
- Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–861
- Lim S, Meigs JB. Epidemiology of NAFLD and type 2 diabetes: Health burden and clinical implications. Nat Rev Endocrinol. 2021;17(1):63–74
- Pipitone RM, Ciccioli C, Infantino G, La Mantia C, Parisi S, Tulone A, Pennisi G, Grimaudo S, Petta S. MAFLD: a multisystem disease. Ther Adv Endocrinol Metab. 2023; 14: 1–23
- Hydes T, Alam U, Cuthbertson DJ. The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories? Front Nutr. 2021;16(8):640557
- Zhao L, Clay-Gilmour A, Zhang J, Zhang X, Steck SE. Higher ultra-processed food intake is associated with adverse liver outcomes: a prospective cohort study of UK Biobank participants. Am J Clin Nutr. 2024;119(1):49-57
- Song M, Bai Y, Song F. High-fat diet and neuroinflammation: The role of mitochondria. Pharmacol Res. 2025;212:107615
- Su X, Li Q, Yang M, Zhang W, Liu X, Ba Y, Deng Q, Zhang Y, Han L, Huang H. Resveratrol protects against a high-fat diet-induced neuroinflammation by suppressing mitochondrial fission via targeting SIRT1/PGC-1α. Exp Neurol. 2024;380:114899
- Ji J, Wu L, Wei J, Wu J, Guo C. The Gut Microbiome and Ferroptosis in MAFLD. Journal of Clinical and Translational Hepatology. 2023;11(1):174–187
- Semmler G, Wöran K, Scheiner B, et al. HFD-fed rodent models for metabolic fatty liver disease—An update and critical review. Nutrients. 2021;13(9):3154
- Petrasek J, Iracheta-Vellve A, Szabo G. The evolving role of rodent models in NAFLD: Bridging nutritional interventions and mechanistic insights. Hepatology Communications. 2023;7(1):e01123
- Svegliati-Baroni G, Marzioni M. Preclinical models of MAFLD: From nutritional overload to fibrosis and NASH. Nat Rev Gastroenterol Hepatol. 2023;20(5):318–331
- Rohbeck P, Lindner D, Schierwagen R, et al. Impact of dietary fat type and content on MAFLD progression in rats. Nutrients. 2022;14(18):3779
- Delli Bovi AP, Parola M, Cannito S. Lipids, inflammation, and fibrosis in MAFLD: Experimental models and translational perspectives. Cells. 2023;12(3):490
- Matran IM, Banescu CV, Talmaci R. Aliment adjuvant in prevenirea/tratamentul steatozei hepatice nealcoolice. BOPI. 2024;11:15
- Stanciu GD and Coman C. Tratat de medicină experimentală: şoareci şi şobolani de laborator. Ed. „Gr. T. Popa”, Iaşi 2022, 59-96
- Jensen VS, Hvid H, Damgaard J, Nygaard H, Ingvorsen C, Wulf EM, Lykkesfeldt J, Fledelius C. Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague–Dawley rats. Diabetol Metab Syndr. 2018;10(4):1-13
- Tessari P, Coracina A, Cosma A, Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutrition, Metabolism & cardiovascular Diseases. 2009; 19:291-302
- Maciejewska D, Lukomska A, Dec K, Skonieczna-Zydecka K, Gutowska I, Skorka-Majewicz M, et al. Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion. Diagnostics (Basel). 2019; 9(4):205-215
- Xu ZJ, Fan JG, Ding XD, Qiao L, Wang GL. Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats. Dig Dis Sci. 2009;55(4):931–940
- Li S, You J, Wang Z, Liu Y, Wang B, Du M, Zou T. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice. Food Research International, 2021; 143: 110270
- Abo-Zaid OA, Moawed FS, Ismail ES, Farrag MA. β-sitosterol attenuates high- fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway. BMC Pharmacol Toxicol, 2023; 24(1):31
- Song L, Qu D, Zhang Q, Jiang J, Zhou H, Jiang R, Li Y, Zhang Y, Yan H. Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet. Nature Scientific Reports. 2017;7: 41604
- Lin HY, Chen CC, Chen YJ, Lin YY, Mersmann HJ, Ding ST. Enhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementations. Biomed Res Int. 2014;2014:1-11
- Lasker S, Rahman MM, Parvez F, Zamila M, Miah P, Nahar K, Kabir F, Sharmin SB, Subhan N, Ahsan GU, Alam MA. High-fat diet-induced metabolic syndrome and oxidative stress in obese rats are ameliorated by yogurt supplementation. Nature Scientific Reports. 2019; 9:20026
- Pettrino C, Argentino-Storino A. Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp Toxicol Pathol. 2006, 57(3):213-219
- Jia YJ, Liu J, Guo YL, Xu RX, Sun J, Li JJ. Dyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing. J Geriatr Cardiol. 2013;10(4):361–368
- Kucera O, Garnol T, Lotkova H, Stankova P, Mazurova Y, Hroch M, Bolehovska R, Rousar T, Cervinkova Z. The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats. Physiol Res. 2011;60(2):317-328
- Mantovani A, Dalbeni A. Treatments for NAFLD: State of Art. Int J Mol Sci. 2021;22:2350
- Rodríguez-Correa E, González-Pérez I, Clavel-Pérez PI, Contreras-Vargas Y, Carvajal K. Biochemical and nutritional overview of diet-induced metabolic syndrome models in rats: what is the best choice? Nutrition and Diabetes. 2020;10:24-39
- Lan T, Yu Y, Zhang J, Li H, Weng Q, Jiang S, Tian S, Xu T, Hu S, Yang G, Zhang Y, Wang W, Wang L, Zhu Q, Rong X, Guo J. Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway. Hepatology. 2021;74(2):686-703
- Hu R. Grifola frondosa may play an anti-obesity role by affecting intestinal microbiota to increase the production of short-chain fatty acids. Front Endocrinol (Lausanne). 2023;13:1-11
Language: English
Page range: 38 - 45
Submitted on: Aug 17, 2025
Accepted on: Nov 3, 2025
Published on: Mar 10, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Rodica Talmaci, Irina Mihaela Matran, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.